Ultragenyx Pharmaceutical Inc. (RARE): Price and Financial Metrics
RARE Price/Volume Stats
| Current price | $40.00 | 52-week high | $60.37 |
| Prev. close | $40.85 | 52-week low | $37.02 |
| Day low | $39.99 | Volume | 795,000 |
| Day high | $41.50 | Avg. volume | 1,213,618 |
| 50-day MA | $45.61 | Dividend yield | N/A |
| 200-day MA | $47.46 | Market Cap | 3.69B |
RARE Stock Price Chart Interactive Chart >
Ultragenyx Pharmaceutical Inc. (RARE) Company Bio
Ultragenyx is a clinical-stage biopharmaceutical company committed to bringing to market novel products for the treatment of rare and ultra-rare diseases, with a focus on serious, debilitating genetic diseases. The company was founded in 2010 and is based in Novato, California.
RARE Price Returns
| 1-mo | -9.54% |
| 3-mo | -26.86% |
| 6-mo | -11.23% |
| 1-year | -10.37% |
| 3-year | -40.45% |
| 5-year | -30.10% |
| YTD | -4.92% |
| 2024 | -12.02% |
| 2023 | 3.22% |
| 2022 | -44.90% |
| 2021 | -39.25% |
| 2020 | 224.12% |
Continue Researching RARE
Want to do more research on Ultragenyx Pharmaceutical Inc's stock and its price? Try the links below:Ultragenyx Pharmaceutical Inc (RARE) Stock Price | Nasdaq
Ultragenyx Pharmaceutical Inc (RARE) Stock Quote, History and News - Yahoo Finance
Ultragenyx Pharmaceutical Inc (RARE) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...